1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of cancer and diabetes
5.1.1.2. Increased in demand due to ability to treat a large number of infectious diseases
5.1.1.3. Advantage of intensive therapy for older patients
5.1.2. Restraints
5.1.2.1. Lack of a significant therapeutic graft-versus-tumor effect
5.1.2.2. Chances of cells contamination with bacteria
5.1.3. Opportunities
5.1.3.1. Rise in investment for extensive research and development
5.1.3.2. Advances in treating various diseases neurodegenerative diseases and macular degeneration
5.1.4. Challenges
5.1.4.1. Risks and complications associated with the therapy
5.2. Cumulative Impact of COVID-19

6. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Type
6.1. Introduction
6.2. Autologous Non-Stem Cells
6.3. Autologous Stem Cells

7. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disease
7.4. Neurodegenerative Disorders
7.5. Orthopedic Diseases
7.6. Others

8. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Research Facilities

9. Americas Autologous Stem Cell & Non-Stem Cell Based Therapies Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Autologous Stem Cell & Non-Stem Cell Based Therapies Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Autologous Stem Cell & Non-Stem Cell Based Therapies Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Antria, Inc
13.2. Bioheart, Inc
13.3. Brainstorm Cell Therapeutics, Inc
13.4. Caladrius Biosciences Inc.
13.5. Castle Creek Biosciences Inc.
13.6. Cytori Therapeutics, Inc.
13.7. Dendreon Corporation
13.8. Fibrocell
13.9. Genesis Biopharma
13.10. Georgia Health Sciences University
13.11. Gilead Sciences Inc.
13.12. Neostem
13.13. Novartis AG
13.14. Opexa Therapeutics
13.15. Orgenesis
13.16. Pharmicell Co. Ltd
13.17. Regeneus
13.18. Regenexx
13.19. Tengion
13.20. TiGenix
13.21. U.S. Stem Cell, Inc.
13.22. VIRxSYS Corporation

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2027
FIGURE 6. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 11. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2027
FIGURE 13. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
FIGURE 14. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 24. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2027
FIGURE 26. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: FPNV POSITIONING MATRIX
FIGURE 63. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: SCORES
TABLE 47. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: BUSINESS STRATEGY
TABLE 48. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: PRODUCT SATISFACTION
TABLE 49. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: RANKING
TABLE 50. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 51. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: MERGER & ACQUISITION
TABLE 52. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: INVESTMENT & FUNDING
TABLE 55. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: LICENSE & PRICING

Companies Mentioned

Antria, Inc
Bioheart, Inc
Brainstorm Cell Therapeutics, Inc
Caladrius Biosciences Inc.
Castle Creek Biosciences Inc.
Cytori Therapeutics, Inc.
Dendreon Corporation
Fibrocell
Genesis Biopharma
Georgia Health Sciences University
Gilead Sciences Inc.
Neostem
Novartis AG
Opexa Therapeutics
Orgenesis
Pharmicell Co. Ltd
Regeneus
Regenexx
Tengion
TiGenix
U.S. Stem Cell, Inc.
VIRxSYS Corporation